Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
2.14 -0.02  (-0.93%)
TradingVolume：4271.3
12-13
2024
COMPLETION OF THE ISSUE OF US$50,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
Publisher：
12-03
2024
APPROVAL OF ZEPZELCA (LURBINECTEDIN FOR INJECTION) FOR MARKETING IN MAINLAND CHINA
Publisher：
12-02
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
Publisher：
11-28
2024
RUOXINLIN AND OTHER DRUGS INCLUDED ON CHINA'S 2024 NATIONAL REIMBURSEMENT DRUG LIST
Publisher：
11-11
2024
APPROVAL OBTAINED FOR CLASS 1 INNOVATIVE ANTIDEPRESSANT LY03021 FOR CLINICAL TRIALS IN CHINA
Publisher：
11-01
2024
OVERSEAS REGULATORY ANNOUNCEMENT
Publisher：
11-01
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
Publisher：
10-30
2024
COMPLETION OF THE ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
Publisher：
10-28
2024
CHANGE OF CLOSING DATE OF THE ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
Publisher：
10-23
2024
PROPOSED ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025 AND US$50,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：4271.3
2.14
-0.02  (-0.93%)
Announcement & Circular
12-13
2024
COMPLETION OF THE ISSUE OF US$50,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
12-03
2024
APPROVAL OF ZEPZELCA (LURBINECTEDIN FOR INJECTION) FOR MARKETING IN MAINLAND CHINA
12-02
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
11-28
2024
RUOXINLIN AND OTHER DRUGS INCLUDED ON CHINA'S 2024 NATIONAL REIMBURSEMENT DRUG LIST
11-11
2024
APPROVAL OBTAINED FOR CLASS 1 INNOVATIVE ANTIDEPRESSANT LY03021 FOR CLINICAL TRIALS IN CHINA
11-01
2024
OVERSEAS REGULATORY ANNOUNCEMENT
11-01
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
10-30
2024
COMPLETION OF THE ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
10-28
2024
CHANGE OF CLOSING DATE OF THE ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
10-23
2024
PROPOSED ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025 AND US$50,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
First
1
2
3
4
5
Last